≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Meningitis, viral

DOID EFO Endpoint Browser PheWeb

G6_MENINGVIR

viral meningitis: Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

159

4. Check minimum number of events

None

159

5. Include endpoints

None

159

6. Filter based on genotype QC (FinnGen only)

159

Control definitions (FinnGen only)

Control exclude
G6_NEUINFL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1037 609 424
Only index persons 980 583 397
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.01
Only index persons 0.02 0.02 0.02
Median age at first event (years)
Whole population 36.25 39.74 31.18
Only index persons 36.97 39.99 32.53

-FinnGen-

Key figures

All Female Male
Number of individuals 159 112 47
Unadjusted period prevalence (%) 0.03 0.04 0.02
Median age at first event (years) 43.09 39.73 51.08

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
144
Matched controls
1440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
87.7
75
*
A87.9
ICD-10 Finland
Viral meningitis, unspecified
568.5
70.0
64
*
J05AB11
ATC
valaciclovir; oral
11.7
31.3
65
94
R51.80
ICD-10 Finland
Headache
9.6
28.7
68
122
TAB00
NOMESCO Finland
Lumbar puncture
27.6
28.5
39
19
G02.0*B02.1
ICD-10 Finland
Zoster meningitis
+∞
26.9
25
*
G02.0
ICD-10 Finland
Meningitis in viral diseases classified elsewhere
+∞
25.8
24
*
G02.0*B01.0
ICD-10 Finland
Varicella meningitis
+∞
21.4
20
*
G02.0*A87.0
ICD-10 Finland
Enteroviral meningitis
+∞
19.2
18
*
G03.9
ICD-10 Finland
Meningitis, unspecified
+∞
19.2
18
*
J05AB01
ATC
aciclovir; systemic
6.1
18.9
61
154
A86
ICD-10 Finland
Unspecified viral encephalitis
141.8
12.6
13
*
AA1AD
NOMESCO Finland
CT of head and brain
4.5
12.3
50
152
B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
11.6
11
*
A87.8
ICD-10 Finland
Other viral meningitis
+∞
11.6
11
*
5AB01
NOMESCO Finland
NA
+∞
10.5
10
*
N01
ICPC
Headache
4.6
9.4
34
90
B02.9
ICD-10 Finland
Zoster without complication
8.4
7.6
16
21
N02BE01
ATC
paracetamol; systemic, rectal
3.9
7.6
129
990
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
16.9
7.4
11
7
N71
ICPC
Meningitis/encephalitis
+∞
7.3
7
*
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
7.3
7
*
B02.1
ICD-10 Finland
Zoster meningitis
+∞
7.3
7
*
ZX120
NOMESCO Finland
Intravenous
4.5
6.7
23
58
XF400
NOMESCO Finland
ECG with 12 standard connections
3.6
6.6
30
97
H02AB06
ATC
prednisolone; systemic
2.5
6.5
75
438
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
72.9
6.5
7
*
B00.4
ICD-10 Finland
Herpesviral encephalitis
+∞
6.3
6
*
A87.0
ICD-10 Finland
Enteroviral meningitis
+∞
6.3
6
*
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
6.3
6
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
6.2
63
339
N03AX16
ATC
pregabalin; oral
2.8
6.0
43
191

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016018) Differential panel - Cerebral spinal fluid
44
10
60.45
76.14
1.4
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
54
26
30.94
74.91
1.6
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
50
35
20.38
58.00
1.5
1.3
e6/l
154.5
3.0
4.19
40
25
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
50
35
20.38
58.00
1.5
1.4
e6/l
21.0
267.7
0.79
41
28
(3023410) Appearance of Cerebral spinal fluid
31
16
23.83
40.75
1.5
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
42
5
112.98
40.08
1.4
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
43
8
72.88
38.71
1.5
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
25
14
21.00
31.43
1.4
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22
14
18.08
25.89
1.4
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
19
14
15.28
20.58
1.3
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
20
17
13.31
19.96
1.4
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
11
16.06
17.87
1.6
1.7
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
21
7
34.23
16.58
1.5
1.1
mmol/l
2.4
1.7
—
21
7
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
5
42.76
15.78
1.3
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
7
32.36
15.62
1.3
1.0
—
—
—
0
0
(4062490)
13
10
14.07
13.53
1.8
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
13
11.71
13.04
1.3
1.3
e6/l
885.6
858.3
—
5
6
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
38
6.22
11.51
1.3
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
79
386
3.08
11.04
5.1
5.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
61
271
3.03
9.90
4.0
4.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
6
23.41
9.52
1.6
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
106
646
2.92
9.36
7.2
5.8
e9/l
1.9
1.9
0.28
98
587
(3001604) Monocytes [#/volume] in Blood
103
624
2.85
9.10
7.2
5.8
e9/l
0.5
0.5
0.32
94
556
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
7
20.04
9.10
1.2
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
13
7
20.04
9.10
1.3
1.0
%
93.1
—
—
7
0
(3006315) Basophils [#/volume] in Blood
103
627
2.82
8.96
7.2
5.8
e9/l
0.0
0.0
0.33
94
560
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
19
7.36
8.58
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
13
9.02
8.56
1.1
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
7
18.38
8.21
3.3
1.3
u/ml
319.8
842.4
—
12
7
(3013115) Eosinophils [#/volume] in Blood
103
645
2.69
8.18
7.4
6.3
e9/l
0.2
0.2
0.38
95
586
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
8
16.08
7.85
1.1
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
28
90
3.56
7.57
1.4
1.2
—
44.0
—
0
5
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
8
14.65
7.00
1.8
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
36
4.83
6.88
1.4
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
35
140
2.92
6.59
2.2
1.9
s
28.8
29.7
0.49
35
135
(40758558) Short blood count panel - Blood
59
309
2.45
6.49
6.0
7.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
108
740
2.43
6.38
9.7
9.2
e9/l
4.1
4.1
0.04
101
653
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
42
190
2.65
6.25
4.2
2.8
ng/l
28.2
76.9
0.74
26
116
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
6
15.78
5.97
1.1
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
79
3.23
5.57
2.0
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
29
118
2.78
5.24
1.6
1.7
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
0
+∞
5.23
1.4
0.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
0
+∞
5.23
1.4
0.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
0
+∞
5.23
1.4
0.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
53
288
2.26
5.20
2.0
1.4
g/l
1.8
2.4
2.12
43
183
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
27
4.73
5.13
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
27
4.73
5.13
1.2
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
51
274
2.27
5.13
1.5
1.7
mg/l
0.6
0.7
0.36
39
204
(3021589) Normoblasts [#/volume] in Blood
83
554
2.04
4.67
9.9
8.7
e9/l
0.0
0.0
0.35
68
451
(3005322) IgE [Units/volume] in Serum or Plasma
21
76
3.03
4.66
1.6
1.2
u/ml
102.5
145.5
0.30
21
66
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
64
394
2.04
4.45
2.9
3.2
ng/l
22.4
20.5
0.13
30
226
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
35
170
2.36
4.39
2.8
2.5
e6/l
3.9
3.5
0.06
14
88
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
116
2.60
4.38
1.6
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
46
3.50
4.31
1.9
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
57
3.22
4.27
1.4
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
28
4.15
4.05
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
48
3.35
4.05
1.1
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
110
837
2.02
4.03
5.3
4.4
—
286.2
—
0
18
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
179
2.22
3.87
1.7
1.8
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
7
8
9.08
3.81
1.4
1.8
e9/l
0.3
0.2
—
7
8
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
12
36
3.52
3.55
4.3
16.6
%
1.5
1.4
0.15
12
31
(3007853) Bacteria identified in Skin by Aerobe culture
27
128
2.34
3.55
1.4
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
13
6.41
3.54
1.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
34
178
2.16
3.54
2.5
2.3
e6/l
0.6
0.8
0.17
13
96
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
6
10.32
3.52
1.3
1.2
u/l
10.2
14.8
—
6
6
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
61
400
1.85
3.35
4.3
3.1
u/l
28.1
29.5
0.25
56
378
(3001122) Ferritin [Mass/volume] in Serum or Plasma
83
602
1.79
3.25
3.1
2.8
ug/l
82.9
84.0
0.04
78
564
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
122
997
1.96
3.21
4.3
4.1
pmol/l
14.5
14.5
0.05
113
922
(46235355) HIV 1 and 2 tests - Meaningful Use set
55
353
1.85
3.21
3.1
2.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
5
10.26
3.00
1.8
1.0
miu/ml
2230.8
966.0
—
5
5
(3052851) Hemolysis interference index of Serum or Plasma
10
30
3.49
2.96
2.0
2.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
17
71
2.56
2.91
1.6
4.0
e9/l
57.2
74.1
1.88
12
56
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
60
408
1.76
2.84
3.9
2.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
6
8.55
2.77
1.2
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
10
32
3.27
2.69
1.3
1.7
nmol/l
45.7
41.0
—
10
32
(3037467) Urinalysis macro (dipstick) panel - Urine
111
905
1.75
2.65
5.8
4.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
145
1292
2.39
2.59
19.5
11.9
mg/l
15.1
20.5
2.34
124
1006
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
7
7.33
2.56
1.6
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
256
1.81
2.56
3.3
2.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
38
234
1.82
2.47
3.1
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68
497
1.64
2.39
2.5
2.4
nmol/l
75.2
75.5
0.03
63
454
(3047181) Lactate [Moles/volume] in Blood
9
29
3.23
2.26
5.2
20.9
mmol/l
1.3
1.1
—
9
23
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
42
2.74
2.23
1.9
1.6
—
—
—
0
0
(4027681)
5
9
5.69
2.23
1.8
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
9
5.69
2.23
2.6
3.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
19
95
2.14
2.21
4.1
11.6
kpa
13.1
12.3
0.35
19
89
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
19
95
2.14
2.21
4.1
11.6
kpa
4.9
5.0
0.17
19
89
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
70
523
1.60
2.21
7.8
7.2
mmol/l
1.2
1.2
1.59
63
439
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
62
2.38
2.14
1.1
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
64
474
1.59
2.07
6.7
6.6
mmol/l
1.2
1.2
1.95
59
437
(3030467) Casts [#/volume] in Urine by Automated count
46
315
1.65
2.04
3.4
2.5
e6/l
0.1
0.5
1.75
31
238
(3044889) 12 lead EKG panel
98
803
1.57
2.02
3.3
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
55
397
1.59
1.96
7.9
7.9
inr
1.2
1.2
0.20
17
125
(3019150) Specific gravity of Urine by Refractometry
41
275
1.66
1.96
3.7
3.9
kg/l
1.0
1.0
—
5
34
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
39
2.67
1.96
5.1
21.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
11
4.65
1.95
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
11
4.65
1.95
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
16
3.85
1.95
1.2
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
60
443
1.57
1.94
4.0
3.4
e6/l
4.7
142.1
1.32
38
298
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
46
2.49
1.90
4.7
3.7
mmol/l
25.3
24.9
0.13
11
46
(3003740) Influenza virus B Ag [Presence] in Specimen
9
34
2.74
1.90
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
34
2.74
1.90
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
133
1185
1.75
1.84
5.4
4.8
mu/l
1.8
1.8
0.03
126
1101
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
59
439
1.55
1.83
2.2
1.8
pmol/l
93.4
95.3
0.12
33
217
(3045414) Leukocytes [Presence] in Urine
11
47
2.44
1.82
1.6
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
66
505
1.52
1.80
2.3
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
50
360
1.57
1.79
3.5
2.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
68
2.16
1.76
1.2
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
53
388
1.55
1.76
3.1
3.2
mmol/l
2.3
2.3
1.41
48
344
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
69
2.13
1.70
1.4
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
23
136
1.81
1.70
1.4
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
49
356
1.54
1.67
3.5
2.8
e6/l
15.1
239.5
0.68
35
277
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
45
321
1.56
1.66
1.2
1.3
u/ml
0.6
1.1
—
9
102
(42529406) Shigella sp [Presence] in Stool by Culture
10
43
2.41
1.64
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
43
2.41
1.64
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
43
2.41
1.64
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
20
115
1.85
1.61
2.0
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
26
2.77
1.60
1.0
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
27
2.66
1.53
1.3
2.7
%
189.3
193.4
—
7
27
(3009542) Hematocrit [Volume Fraction] of Blood
134
1215
1.65
1.50
18.8
12.0
%
39.9
40.4
0.29
105
973
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
45
2.30
1.50
2.9
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
44
321
1.51
1.46
3.0
2.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
16
3.19
1.45
1.2
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
16
3.19
1.45
1.0
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
16
3.19
1.45
1.0
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
22
2.79
1.45
1.2
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
128
1.74
1.42
3.8
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
29
2.48
1.41
1.1
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
75
1.95
1.39
3.8
5.9
mmol/l
1.1
1.5
0.85
14
69
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
17
3.00
1.37
1.2
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
17
3.00
1.37
1.2
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
17
3.00
1.37
1.0
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
84
1.87
1.32
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
84
1.87
1.32
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
34
2.42
1.31
1.5
1.2
—
—
—
0
0
(3012544) pH of Venous blood
15
85
1.84
1.28
2.5
3.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
85
1.84
1.28
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
116
1033
1.45
1.28
3.9
3.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
19
2.68
1.22
1.0
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
79
1.85
1.21
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
159
1.60
1.21
1.5
1.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
15
87
1.80
1.20
4.8
12.4
%
97.6
94.9
1.69
15
82
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
6
26
2.36
1.20
1.0
1.3
u/ml
350.3
273.6
—
6
16
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
26
2.36
1.20
1.0
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
22
143
1.62
1.19
3.2
2.3
g/l
2.3
2.5
0.83
22
129
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
70
578
1.38
1.17
4.4
4.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
137
1269
1.58
1.16
20.3
12.5
mmol/l
3.9
3.9
0.42
137
1227
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
20
2.55
1.16
1.0
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
40
2.05
1.14
5.0
2.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
131
1205
1.49
1.12
3.9
3.8
mmol/l
5.7
5.7
0.37
123
1122
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
145
1366
1.70
1.08
13.7
9.1
u/l
25.3
25.2
0.03
145
1326
(3000991) Gas panel - Venous blood
12
67
1.86
1.08
2.6
7.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
43
331
1.41
1.07
1.8
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
33
2.17
1.07
1.1
2.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
22
2.31
1.04
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
191
1.50
1.03
2.6
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
84
1.73
1.01
1.4
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
17
108
1.64
1.01
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
15
92
1.70
1.01
5.4
3.7
ug/l
2.2
76.7
—
10
78
(40768443) Skin Pathology biopsy report
9
49
1.89
1.00
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
28
2.19
0.92
1.2
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
28
2.19
0.92
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
28
2.19
0.92
1.0
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
111
1.60
0.92
1.5
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
40
313
1.37
0.90
7.3
5.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
29
2.11
0.90
1.8
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
129
1.54
0.88
1.7
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
75
652
1.28
0.81
6.6
4.8
estimate
0.0
0.0
—
10
137
(3035350) Ketones [Presence] in Urine by Test strip
75
652
1.28
0.81
4.6
3.5
estimate
0.0
0.0
—
9
140
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
75
1.65
0.77
1.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
75
1.65
0.77
1.3
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
34
1.79
0.77
1.2
1.1
—
1.1
—
0
5
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
128
1199
1.35
0.74
15.3
10.4
ml/min/173m2
89.5
88.5
0.19
119
964
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
25
2.03
0.73
1.0
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
25
2.03
0.73
1.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
25
2.03
0.73
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
25
2.03
0.73
1.6
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
57
1.61
0.72
1.6
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
85
1.58
0.71
1.4
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
26
1.95
0.71
3.0
3.2
mmol/l
22.3
22.6
—
5
21
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
26
1.95
0.71
1.2
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
58
1.58
0.71
7.8
3.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
77
1.60
0.71
1.5
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
61
1.68
0.70
4.8
11.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
75
661
1.25
0.70
4.6
3.6
estimate
0.0
0.0
—
10
134
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
36
289
1.32
0.69
1.8
1.7
—
—
—
0
0
(4010399)
13
86
1.56
0.68
1.2
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
18
129
1.45
0.67
9.5
7.1
mmol/l
1.0
1.1
0.20
18
117
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
104
1.49
0.65
3.7
3.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
21
156
1.40
0.65
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
79
1.56
0.64
1.7
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
183
1.37
0.64
1.3
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
29
1.75
0.64
1.4
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
166
1.38
0.63
5.0
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
34
275
1.30
0.62
1.4
1.4
nmol/l
24.0
22.1
0.50
27
228
(3018418) pH of Serum or Plasma
39
322
1.28
0.61
7.3
4.2
ph
7.4
7.4
—
5
63
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
128
1209
1.30
0.61
3.2
3.4
mmol/l
1.2
1.2
0.75
118
1128
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
51
1.60
0.61
2.7
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
276
1.29
0.61
1.7
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
52
1.57
0.60
1.1
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
55
1.48
0.57
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
316
1.27
0.57
1.4
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
38
1.60
0.55
1.5
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
9
61
1.50
0.55
5.8
13.8
mmol/l
25.0
24.1
—
9
55
(21494755) Public health laboratory ask at order entry panel
14
191
0.71
0.55
1.7
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
33
271
1.27
0.54
2.8
3.2
mg/l
44.0
353.3
0.62
19
170
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
126
1.39
0.54
1.2
1.3
iu/ml
25.6
117.4
—
5
50
(40761511) CBC panel - Blood by Automated count
143
1378
1.38
0.53
17.1
10.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
119
1124
1.23
0.50
4.8
4.8
mmol/mol
37.5
38.7
1.04
113
1064
(40761536) Microorganisms panel - Urine sediment
8
118
0.66
0.48
6.4
3.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
150
1464
1.43
0.45
26.7
17.3
fl
90.6
90.5
0.14
150
1443
(3014007) Fractional oxyhemoglobin in Arterial blood
7
51
1.39
0.44
3.4
9.2
%
96.1
93.7
—
7
51
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
31
1.63
0.43
2.4
3.1
e9/l
3.2
4.0
—
5
31
(3011397) Hemoglobin [Presence] in Urine by Test strip
34
289
1.22
0.43
4.1
3.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
32
1.58
0.42
2.4
3.3
%
57.0
54.6
—
5
32
(1761482) Bacteria [#/volume] in Urine by Culture
5
33
1.53
0.41
8.8
4.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
59
1.37
0.41
1.3
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
13.6
—
1786.4
—
0
16
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
11.6
—
935.7
—
0
16
(3044640) Blood type and Crossmatch panel - Blood
43
376
1.20
0.41
2.0
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
142
1.30
0.40
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
44
386
1.19
0.40
4.3
3.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
2.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
19
0.00
0.39
0.0
1.5
—
13.6
—
0
19
(3029937) Albumin [Presence] in Urine by Test strip
30
349
0.83
0.37
5.9
3.9
estimate
0.0
0.0
—
10
131
(3025159) Blasts/100 leukocytes in Blood
12
90
1.36
0.37
6.3
4.5
—
0.0
—
0
21
(3000963) Hemoglobin [Mass/volume] in Blood
150
1467
1.40
0.37
26.9
17.4
g/l
134.5
135.3
0.32
150
1446
(3035941) MCH [Entitic mass]
150
1465
1.42
0.36
26.7
17.2
pg
30.4
30.1
0.93
150
1443
(3020682) Albumin/Creatinine [Ratio] in Urine
33
286
1.19
0.35
4.1
3.8
mg/mmol
17.7
12.8
0.15
17
179
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
6
45
1.35
0.34
1.2
2.9
g/l
1.0
1.3
—
6
40
(3008898) HLA-B27 [Presence]
6
88
0.67
0.34
1.2
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
47
1.29
0.32
3.5
3.1
%
53.2
48.6
—
6
47
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
250
1.20
0.32
1.3
1.3
iu/ml
9.8
27.4
—
8
88
(3015736) pH of Urine
56
511
1.15
0.32
4.3
3.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
53
1.34
0.31
3.4
8.9
%
0.7
0.8
—
7
53
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
54
1.31
0.31
3.4
8.3
%
1.2
1.6
—
7
54
(3023511) Choriogonadotropin [Units/volume] in Urine
7
55
1.29
0.30
1.1
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
57
1.24
0.29
1.6
2.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
86
1.30
0.27
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
55
508
1.13
0.26
5.2
3.6
—
—
—
0
0
(4035726)
12
96
1.27
0.25
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
12
97
1.26
0.23
3.4
4.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
41
1.23
0.22
1.0
1.3
—
1.9
—
0
5
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
41
1.23
0.22
1.0
1.3
—
10.1
—
0
10
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
130
1267
1.14
0.22
3.7
3.8
mmol/l
4.7
4.7
0.15
125
1193
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
11
134
0.81
0.21
3.1
4.0
%
26.2
31.8
—
5
86
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
5.0
—
0
10
(40768806) Pleura Pathology biopsy report
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
105.8
—
0
10
(40768800) Prostate Pathology biopsy report
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
12
0.00
0.21
0.0
2.3
—
59.2
—
0
12
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(4268621)
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
4.1
—
22.6
—
0
14
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
156
1.17
0.19
1.8
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
109
1.21
0.19
1.5
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
20
176
1.16
0.18
3.3
3.9
%
28.9
22.7
—
9
81
(3004119) Hemoglobin [Mass/volume] in Venous blood
7
59
1.19
0.18
2.0
3.5
g/l
129.4
131.4
—
7
59
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
65
0.76
0.17
1.6
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
27
245
1.12
0.16
1.2
1.3
u/ml
1.5
12.0
—
10
96
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
79
0.75
0.16
1.7
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
129
1264
1.11
0.15
3.7
3.7
mmol/l
1.5
1.5
0.07
122
1186
(3019832) Treponema pallidum Ab [Presence] in Serum
25
227
1.12
0.15
2.4
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
139
0.85
0.14
1.4
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
55
522
1.08
0.14
2.3
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
127
0.86
0.13
9.6
6.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
15
135
1.12
0.10
2.0
2.8
ug/l
0.8
0.7
—
9
87
(3022313) Gas panel - Capillary blood
5
45
1.11
0.10
1.4
3.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
45
1.11
0.10
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
130
1282
1.08
0.09
4.3
4.0
mmol/l
2.7
2.8
0.64
125
1199
(1002224) Polysomnography panel
7
64
1.10
0.08
1.1
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
7
64
1.10
0.08
2.4
2.9
kpa
4.9
5.0
—
7
58
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
6
73
0.82
0.08
1.7
1.9
ug/l
5.7
2.6
—
6
63
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
74
1.09
0.07
1.5
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
10
90
1.12
0.05
2.2
2.6
u/l
221.3
4511.2
—
5
39
(3002179) Metamyelocytes/100 leukocytes in Blood
10
92
1.09
0.03
6.5
4.5
—
0.6
—
0
18
(3013512) EKG study
30
293
1.03
0.01
3.6
3.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
40
394
1.02
0.00
1.5
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
17
168
1.01
0.00
2.0
2.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
54.0
—
0
6
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
72
0.97
0.00
1.3
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
10.2
—
0
5
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
1.7
—
1671.4
—
0
7
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
14.9
—
0
7
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.3
—
1.9
—
0
5
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
63
0.95
0.00
1.3
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
30
300
1.00
0.00
1.8
2.8
umol/l
329.3
8410.0
1.73
25
267
(40761535) Cells panel - Urine sediment
8
89
0.89
0.00
7.6
3.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
24.0
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
444.2
—
0
5
(44813793)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
14.3
—
0
5
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
217.0
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
65
0.92
0.00
1.7
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
72
0.97
0.00
1.3
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.7
—
13.1
—
0
7
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
72
0.97
0.00
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
72
0.97
0.00
1.3
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
89
0.89
0.00
1.7
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
49
1.02
0.00
2.6
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
63
0.95
0.00
1.3
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MENINGVIR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_MENINGVIR.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: G6_MENINGVIR – Meningitis, viral

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data